Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1002957 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-P21-Activated Kinase 4 (PAK4) antibody
- Antibody type
- Polyclonal
- Antigen
- PAK4 antibody was raised against a 13 amino acid peptide from near the center of human PAK4.
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 µg
- Storage
- -20°C Shipping Temperature: 4°C
- Handling
- Antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures. During shipment, small volumes of antibody will occasionally become entrapped in the seal of the product vial. For products with volumes of 200 myl or less, we recommend gently tapping the vial on a hard surface or briefly centrifuging the vial in a tabletop centrifuge to dislodge any liquid in the container’s cap.
Submitted references p21-Activated kinase 5 (Pak5) localizes to mitochondria and inhibits apoptosis by phosphorylating BAD.
p21-activated kinases: three more join the Pak.
PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia.
Cotteret S, Jaffer ZM, Beeser A, Chernoff J
Molecular and cellular biology 2003 Aug;23(16):5526-39
Molecular and cellular biology 2003 Aug;23(16):5526-39
p21-activated kinases: three more join the Pak.
Jaffer ZM, Chernoff J
The international journal of biochemistry & cell biology 2002 Jul;34(7):713-7
The international journal of biochemistry & cell biology 2002 Jul;34(7):713-7
PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia.
Abo A, Qu J, Cammarano MS, Dan C, Fritsch A, Baud V, Belisle B, Minden A
The EMBO journal 1998 Nov 16;17(22):6527-40
The EMBO journal 1998 Nov 16;17(22):6527-40
No comments: Submit comment
No validations: Submit validation data